Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4A | O75164 | 12/20 | 0.44 |
| ▸ | KDM4C | Q9H3R0 | 12/20 | 0.44 |
| ▸ | KDM5A | P29375 | 1/20 | 0.44 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.44 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.44 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15028239 | 1.00 | KDM4A (0.44) | KDM4AKDM4CKDM5AKDM7APHF8 | |
| SCHEMBL20490773 | 1.00 | KDM4A (0.44) | KDM4AKDM4CKDM5AKDM7APHF8 | |
| SCHEMBL15027342 | 1.00 | KDM4A (0.44) | KDM4AKDM4CKDM5AKDM7APHF8 | |
| SCHEMBL20490781 | 0.94 | MAPK1 (0.53) | MAPK1MAPTCYP1A2LMNAMEN1 | |
| SCHEMBL20490776 | 0.94 | MAPK1 (0.53) | MAPK1MAPTCYP1A2LMNAMEN1 | |
| SCHEMBL23676366 | 0.94 | KDM4A (0.40) | KDM4AKDM4CKDM5AKDM7APHF8 | |
| SCHEMBL17124043 | 0.94 | GPR84 (0.44) | KDM4AKDM4CKDM5AKDM7APHF8 | |
| SCHEMBL20490754 | 0.94 | MAPK1 (0.53) | MAPK1MAPTCYP1A2LMNAMEN1 | |
| SCHEMBL29072283 | 0.94 | MAPK1 (0.53) | MAPK1MAPTCYP1A2LMNAMEN1 | |
| SCHEMBL29959266 | 0.94 | MAPK1 (0.53) | MAPK1MAPTCYP1A2LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090590-A1 | NANOPARTICLE FORMULATIONS FOR THE DELIVERY OF DNA TO ADIPOSE TISSUE | Remedium Bio, Inc. (US) | 2026-04-30 | — | — | WO | claimed |
| EP-4591859-A1 | LIPID NANOPARTICLE, PREPARATION METHOD THEREFOR, AND USE THEREOF | INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2025-07-30 | — | — | EP | claimed |
| US-20250213496-A1 | LIPID NANOPARTICLES AND PREPARATION METHODS AND USE THEREOF | INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2025-07-03 | — | — | US | claimed |
| WO-2024259158-A2 | LIPID NANOPARTICLES FOR PEPTIDE DELIVERY AND METHODS OF MAKING AND USING THE SAME | CORNELL UNIVERSITY (US) | 2024-12-19 | — | — | WO | claimed |
| CN-118302155-A | Method for freezing and freeze-drying Lipid Nanoparticles (LNPs) and LNPs obtained thereby | 赛诺菲 | 2024-07-05 | — | — | CN | claimed |
| CN-118059061-A | Preparation method and application of lipid nanoparticle for efficiently delivering nucleic acid drug | 中国科学院化学研究所 | 2024-05-24 | — | — | CN | claimed |
| CN-118045169-A | Lipid-charged molecule conjugate, inhalable lipid nanoparticle, and preparation method and application thereof | 中国科学院化学研究所 | 2024-05-17 | — | — | CN | claimed |
| EP-4351615-A2 | MULTIPLEXED TP53 AND PAN-RAS MRNA CANCER VACCINES | Rnaimmune, Inc. (US) | 2024-04-17 | — | — | EP | claimed |
| CN-116904486-A | Dabiebanda virus mRNA, and pharmaceutical composition and application thereof | 宁波大学 | 2023-10-20 | — | — | CN | claimed |
| CN-116763756-A | Lipid nanoparticle and preparation method and application thereof | 中国科学院化学研究所 | 2023-09-19 | — | — | CN | claimed |
| EP-4228679-A1 | PAN-RAS MRNA CANCER VACCINES | Rnaimmune, Inc. (US) | 2023-08-23 | — | — | EP | claimed |
| US-20230241002-A1 | METHODS FOR PREPARING PARTICLES AND RELATED COMPOSITIONS | MODERNATX, INC. (US) | 2023-08-03 | — | — | US | claimed |
| EP-4153244-A1 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2023-03-29 | — | — | EP | claimed |
| WO-2022261514-A2 | MULTIPLEXED TP53 AND PAN-RAS MRNA CANCER VACCINES | RNAimmune, Inc. (US) | 2022-12-15 | — | — | WO | claimed |
| WO-2022081764-A1 | PAN-RAS mRNA CANCER VACCINES | RNAimmune, Inc. (US) | 2022-04-21 | — | — | WO | claimed |
| CN-114306279-A | Lipid nanoparticle system based on corosolic acid or analogues thereof, and preparation method and application thereof | 复旦大学 | 2022-04-12 | — | — | CN | claimed |
| WO-2021236855-A1 | CIRCULAR RNA COMPOSITIONS AND METHODS | ORNA THERAPEUTICS, INC. (US) | 2021-11-25 | — | — | WO | claimed |
| EP-3849589-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER USING MRNA THERAPEUTICS | ModernaTX, Inc. (US) | 2021-07-21 | — | — | EP | claimed |
| EP-3325505-B1 | MESSENGER RIBONUCLEIC ACIDS FOR THE PRODUCTION OF INTRACELLULAR BINDING POLYPEPTIDES AND METHODS OF USE THEREOF | MODERNATX INC (US) | 2020-08-19 | — | — | EP | claimed |
| WO-2020056304-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER USING MRNA THERAPEUTICS | MODERNATX, INC. (US) | 2020-03-19 | — | — | WO | claimed |